tirzepatide getz pharma launches Tirzee Inj, a new diabetes and obesity treatment. | Afzaal Ahmad posted on the topic Tirzepatide # by Getz A

Because there was no prespecified plan for adjustment of the widths of the confidence intervals of secondary end points for multiplicity, the intervals may not be used in place of hypothesis testing and no definite conclusions can be drawn from these results

PubMed laboratory research record [PMID: 38443005] PubMed record related to this compound for laboratory literature review

Obesity is a chronic disease that often requires ongoing management, similar to other chronic diseases like hypertension or diabetes

What was once limited to expensive in-person specialist visits is now available to anyone with an internet connection

Early symptoms usually start within one to four days of the last dose and include rebound anxiety, insomnia, tremor, sweating, and a racing heart

As a dual receptor agonist, it mimics the actions of two natural hormonesGLP-1 and GIPthat regulate appetite, insulin production, and digestion